1
|
Dutilloy E, Arias AA, Richet N, Guise JF, Duban M, Leclere V, Selim S, Jacques P, Jacquard C, Clément C, Ait Barka E, Esmaeel Q. Bacillus velezensis BE2 controls wheat and barley diseases by direct antagonism and induced systemic resistance. Appl Microbiol Biotechnol 2024; 108:64. [PMID: 38189957 DOI: 10.1007/s00253-023-12864-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2023] [Revised: 10/19/2023] [Accepted: 11/05/2023] [Indexed: 01/09/2024]
Abstract
Wheat and barley rank among the main crops cultivated on a global scale, providing the essential nutritional foundation for both humans and animals. Nevertheless, these crops are vulnerable to several fungal diseases, such as Septoria tritici blotch and net blotch, which significantly reduce yields by adversely affecting leaves and grain quality. To mitigate the effect of these diseases, chemical fungicides have proven to be genuinely effective; however, they impose a serious environmental burden. Currently, biocontrol agents have attracted attention as a sustainable alternative to fungicides, offering an eco-friendly option. The study aimed to assess the efficacy of Bacillus velezensis BE2 in reducing disease symptoms caused by Zymoseptoria tritici and Pyrenophora teres. This bacterium exhibited significant antagonistic effects in vitro by suppressing fungal development when pathogens and the beneficial strain were in direct confrontation. These findings were subsequently confirmed through microscopic analysis, which illustrated the strain's capacity to inhibit spore germination and mycelial growth in both pathogens. Additionally, the study analysed the cell-free supernatant of the bacterium using UPLC-MS (ultra-performance liquid chromatography-mass spectrometry). The results revealed that strain BE2 produces, among other metabolites, different families of cyclic lipopeptides that may be involved in biocontrol. Furthermore, the beneficial effects of strain BE2 in planta were assessed by quantifying the fungal DNA content directly at the leaf level after bacterization, using two different application methods (foliar and drenching). The results indicated that applying the beneficial bacterium at the root level significantly reduced pathogens pressure. Finally, gene expression analysis of different markers showed that BE2 application induced a priming effect within the first hours after infection. KEY POINTS: • BE2 managed Z. tritici and P. teres by direct antagonism and induced systemic resistance. • Strain BE2 produced seven metabolite families, including three cyclic lipopeptides. • Application of strain BE2 at the root level triggered plant defense mechanisms.
Collapse
Affiliation(s)
- Emma Dutilloy
- Université de Reims Champagne Ardenne, INRAE, RIBP USC 1488, 51100, Reims, France
| | - Anthony Arguëlles Arias
- Microbial Processes and Interactions Laboratory, Terra Teaching and Research Center, Gembloux Agro-Bio Tech, University of Liège, Gembloux, Belgium
| | - Nicolas Richet
- Université de Reims Champagne Ardenne, Plateau Technique Mobile de Cytométrie Environnementale MOBICYTE, URCA/INERIS, UFR Sciences Exactes Et Naturelles, Reims, France
| | - Jean-François Guise
- Université de Reims Champagne Ardenne, INRAE, RIBP USC 1488, 51100, Reims, France
| | - Matthieu Duban
- Université de Lille, Université de Liège, UMRT, 1158 BioEcoAgro, Institut Charles Viollette, 59000, Lille, France
| | - Valérie Leclere
- Université de Lille, Université de Liège, UMRT, 1158 BioEcoAgro, Institut Charles Viollette, 59000, Lille, France
| | - Sameh Selim
- AGHYLE UP 2018.C101, SFR Condorcet FR CNRS 3417, Institut Polytechnique UniLaSalle, 19 Rue Pierre Waguet, BP 30313, F-60026, Beauvais Cedex, France
| | - Philippe Jacques
- Microbial Processes and Interactions Laboratory, Terra Teaching and Research Center, Gembloux Agro-Bio Tech, University of Liège, Gembloux, Belgium
| | - Cédric Jacquard
- Université de Reims Champagne Ardenne, INRAE, RIBP USC 1488, 51100, Reims, France
| | - Christophe Clément
- Université de Reims Champagne Ardenne, INRAE, RIBP USC 1488, 51100, Reims, France
| | - Essaïd Ait Barka
- Université de Reims Champagne Ardenne, INRAE, RIBP USC 1488, 51100, Reims, France
| | - Qassim Esmaeel
- Université de Reims Champagne Ardenne, INRAE, RIBP USC 1488, 51100, Reims, France.
| |
Collapse
|
2
|
Abstract
High-performance capillary electrophoresis (HPCE) with UV absorbance detection (254 nm) has been applied for analyzing intracellular free ribonucleotides. The nucleotide profiles obtained from peripheral blood lymphocytes differ from those obtained from Molt4 human leukemic cells. With a 140 mM borate buffer, pH 9.4, a nearly complete profile can be obtained in 25 min. HPCE has comparable resolution to that of high-performance liquid chromatography (HPLC) but is faster in terms of time per sample run (25 min vs 45 min) and requires much less sample (nanoliter range for HPCE vs microliter range for HPLC).
Collapse
Affiliation(s)
- M Ng
- Division of Clinical Pharmacology, Stanford University School of Medicine, Stanford University, California 94305-5463
| | | | | | | |
Collapse
|
3
|
Abstract
The separation of protein mixtures by capillary zone electrophoresis can be plagued by wall adsorption of the protein components, causing peak broadening and distortion. A method is presented for overcoming this problem by adding ethylene glycol to the protein sample and by choosing the running buffer and protein sample to be at different pH values and molarities. This protocol appears to work for a wide class of proteins having different molecular weights and pI values. The method has been applied to the analysis of proteins in human serum. Compared to the traditional method of agarose gel electrophoresis, the present method is more rapid and offers better resolution, suggesting its potential as a clinical diagnostic of certain disease states.
Collapse
Affiliation(s)
- M J Gordon
- Department of Chemistry, Stanford University, California 94305
| | | | | | | |
Collapse
|